Ovodan Biotech A/S Secures DKK 8.5 million GUDP Investment

The potential 

A groundbreaking annual reduction of 4,000 tons of CO2 emissions, a decrease in water consumption by 60,507 m³, and reduced emissions of CH4, N2O, and NH3. All from Ovodan alone.

This innovative solution will entirely replace animal-based lysozyme production with an environmentally friendly alternative, delivering substantial ecological benefits. Moreover, the new method ensures supply chain security in response to increasing demand for lysozyme as a natural alternative to chemical additives. 

A gamechanging development  

At the heart of the project is the development of a sustainable, recombinant lysozyme production process. This alternative to the current egg-based technology promises significant green benefits for Denmark and beyond. If successful, the ReLy project will drive substantial growth for Ovodan Foods while enhancing the consortium’s expertise in establishing and scaling non-animal, bio-based production. 

About Ovodan Biotech A/S

Ovodan Foods (formerly Sanovo Foods) belongs to the Thornico concern andwas founded in 1942 in Odense, Denmark, where its headquarters remain today. The company is a part of Ovodan Egg Group that has a turnover of €230 million and employs approximately 600 people worldwide. Ovodan’s core activities focus on the production and distribution of egg-based solutions, and its global presence spans over 70 countries through factories, sales offices, agents, and distributors. Founded in 2011 Ovodan Biotech produces chicken antibodies for in-vitro diagnostic industry as well as supports the research and development activities in the Ovodan Egg Group and the entire Thornico concern. 

With this groundbreaking project, Ovodan Biotech reinforces Odense’s position as a hub for innovation and sustainability. The collaboration exemplifies how targeted investments can drive significant environmental and economic benefits, paving the way for a greener, more secure future.

Further information